The dietary supplement industry in the US faces increasing class action risk driven by labeling, testing, and compliance claims. Courts continue to apply the reasonable consumer standard when assessing plausibility, and recent decisions emphasizing that context, qualifiers, and disclaimers matter have strengthened that defense. This article examines current trends in class action lawsuits, including challenges to FDA disclaimers for structure/function claims, inaccurate protein %DV declarations, and discrepancies in labeled ingredient amounts. It also addresses lawsuits targeting 'greenwashing,” slack-fill, and synthetic ingredient claims and underscoring the importance of substantiated, contextual labeling and proactive compliance strategies.
